Scribd Logo
Upload

Welcome to Scribd!

  • 2 views

    Book 4

    Uploaded by

    jingbingcol

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd

    Book 4

    Uploaded by

    jingbingcol
    2 views5 pages

    Original Title

    Book4

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    2 views5 pages

    Book 4

    Uploaded by

    jingbingcol

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    You are on page 1of 5

    reference country/disease design

    cai [281,2012 China/asthma Rcr


    Chan et al. [301,2006] China/asthma RDBCT
    Chen [20],2013 China/asthma RCT
    Hu et al. [33],2019 China/asthma RCT
    Li [32],2.018 China/asthma RCT
    Li [21],2014 China/asthma RCT
    Li [29],2013 China/asthma RCT
    Ma [311,2001 China/asthma RCT
    Tan and Zhang [22], 2013 China/asthma RPCCr
    wang [23],2010 China/asthma RCT
    Wen et al. [24],2016 China/asthma RCT
    Xu and Shen [25],1994 China/asthma RCT
    Yan [261,2012 China/asthma RCT
    Zhou [27],2012 China/asthma RCr
    Age
    sample size(intervention group/control group
    intervention group
    100 (50/50) < 1-12 years
    52 (28/24) 9.44—9.98 years
    68 (34/34) 5.3±1.7 years
    96 (48/48) 8.67±2.11 years
    96 (48/48) 5.7±2.2 years
    240 (120/120) 5.8±2.6 years
    120 (60/60) 8.0±3.3 years
    60 (30/30) 9.4±3.5 years
    60 (30/30) 9.2±0.81 years
    76 (38/38) 2-15 years
    150 (75/75), 40 (20/20) 5-14 years
    60 (30/30) 33—13 years
    80 (40/40) 5.4 years
    86 (43/43) 5.2±1.7 years
    Age disease duration
    control group intervention group control group
    < 1-12 years NR NR
    9.67-10.93 years 3.83-4.37 years 3.62—5.38 years
    5.2±1.9 years 1.5±1.1 years 1.4±0.9 years
    8.62±2.09 years 2..34±.225 years 2.39±0.23 years
    5.7±2.2 years 6.2±2.6 months 62±2.6 months
    5.9±2.7 years 1.5±0.6 years 1.4±0.7 years
    7.8±3.7 years 1—4.5 years 0.5—5 years
    9.3±4.5 years 6.8±2.4 months 7.2±2.2 months
    9.5±0.88 years 5 days 5 days
    3—14 years 2. months to 3 years 3 months to 3 years
    5—14 years NR NR
    33— 13 years NR NR
    5.4 years NR NR
    5.1±1.9 years 1.5±1.2 years 1.4±0.9 years
    treatment time
    1 week
    12 weeks
    12 days
    2 weeks
    14 days
    14 days
    27 days
    3 days
    7 days
    9 days
    2 weeks
    1 weeks
    7 days
    7 days
    course of treatment outcomes
    clinical effectiveness rate, FEVI, PEF
    FEVI%, rgE
    clinical effectiveness rate
    clinical effectiveness rate, FEVI
    clinical effectiveness rate, FEVI improvement rate, PEF improvement rate, lgE
    clinical effectiveness rate
    clinical effectiveness rate, FEVI improvement rate, PEF improvement rate, lgE
    FEVI improvement rate, PEF improvement rate
    clinical effectiveness rate, FEVI improvement rate, PEF improvement rate
    clinical effectiveness rate
    clinical effectiveness rate, increase in FEVI, PEF mutation rate
    clinical effectiveness rate
    clinical effectiveness rate, eosinophil count
    clinical effectiveness rate, eosinophil count

    You might also like